Warren, R.; Sofen, H.; Imafuku, S.; Szepietowski, J.; Blauvelt, A.; Spelman, L.; Toms, J.; Buck, A.; Banerjee, S.; Menter, A. Deucravacitinib Long-Term Efficacy and Safety in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program. J of Skin 2022, 6, s48.